Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMC 3516578)

Published in PLoS Negl Trop Dis on December 06, 2012

Authors

Katy L Hamlin1, Delynn M Moss, Jeffrey W Priest, Jacquelin Roberts, Joseph Kubofcik, Katherine Gass, Thomas G Streit, Thomas B Nutman, Mark L Eberhard, Patrick J Lammie

Author Affiliations

1: Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Articles citing this

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl Trop Dis (2013) 1.64

Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PLoS One (2014) 1.14

Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. Clin Vaccine Immunol (2013) 1.06

Longitudinal evaluation of enteric protozoa in Haitian children by stool exam and multiplex serologic assay. Am J Trop Med Hyg (2014) 1.00

Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases. Transl Res (2014) 0.98

Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg (2015) 0.89

Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection. Clin Vaccine Immunol (2015) 0.86

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame. PLoS Negl Trop Dis (2016) 0.84

Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in Cambodia. PLoS Negl Trop Dis (2016) 0.84

Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012. Clin Vaccine Immunol (2016) 0.83

Development of Ss-NIE-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis. PLoS Negl Trop Dis (2015) 0.81

Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history. PLoS Negl Trop Dis (2013) 0.78

An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa. Pan Afr Med J (2017) 0.77

Measuring Haitian children's exposure to chikungunya, dengue and malaria. Bull World Health Organ (2016) 0.76

Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels. PLoS Negl Trop Dis (2017) 0.75

Serological Responses to Filarial Antigens in Malian Children Attending Elementary Schools. Am J Trop Med Hyg (2016) 0.75

Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya. Parasit Vectors (2017) 0.75

Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination program. Parasit Vectors (2015) 0.75

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration. PLoS Negl Trop Dis (2017) 0.75

Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages. PLoS One (2017) 0.75

Articles cited by this

Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet (2006) 5.05

The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis (2008) 4.36

Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63

Diagnostic tools for filariasis elimination programs. Trends Parasitol (2006) 3.23

A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis (2012) 3.16

Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96

Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J (2004) 2.35

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89

Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am J Trop Med Hyg (1999) 1.74

Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010. Wkly Epidemiol Rec (2011) 1.73

The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun (2000) 1.50

Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. Am J Trop Med Hyg (2011) 1.45

Lymphatic filariasis: an infection of childhood. Trop Med Int Health (2001) 1.40

Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol Biochem Parasitol (1994) 1.32

Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis (2012) 1.23

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet (1997) 1.22

Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg (1998) 1.21

Maternal filarial infection as risk factor for infection in children. Lancet (1991) 1.19

Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg (1994) 1.18

Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA). PLoS Negl Trop Dis (2012) 1.15

Laboratory diagnosis of filariasis. Clin Lab Med (1991) 1.13

Epidemiology of Wuchereria bancrofti in Leogane, Haiti. Trans R Soc Trop Med Hyg (1988) 1.13

Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection. Ann Trop Med Parasitol (2009) 1.02

Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm-33). Microbiol Immunol (2009) 1.01

Detection of serum IgG antibodies specific for Wolbachia surface protein in rhesus monkeys infected with Brugia malayi. J Infect Dis (2001) 1.01

An increase in hookworm infection temporally associated with ecologic change. Emerg Infect Dis (1997) 1.00

Eliminating lymphatic filariasis--the surveillance challenge. Trop Med Int Health (2008) 1.00

Preliminary findings from a cross-sectional study on lymphatic filariasis in children, in an area of India endemic for Brugia malayi infection. Ann Trop Med Parasitol (2007) 0.96

Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin Vaccine Immunol (2010) 0.93

Expression of an Onchocerca volvulus Ov33 homolog in Dirofilaria immitis: potential in immunodiagnosis of heartworm infection. Parasite Immunol (1994) 0.88

Antibody to the Dirofilaria immitis aspartyl protease inhibitor homologue is a diagnostic marker for feline heartworm infections. J Parasitol (1998) 0.86

Ultrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment. Am J Trop Med Hyg (2005) 0.83

Articles by these authors

Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev (2004) 5.41

Draft genome of the filarial nematode parasite Brugia malayi. Science (2007) 5.28

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04

A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65

Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood (2003) 2.61

Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J Immunol (2006) 2.29

Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med (2003) 2.28

Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis (2010) 2.23

A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med (2009) 2.21

Malignant Transformation of Hymenolepis nana in a Human Host. N Engl J Med (2015) 2.21

Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis (2009) 2.20

The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 2.13

Zoonotic helminths affecting the human eye. Parasit Vectors (2011) 2.05

Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. J Invest Dermatol (2004) 1.98

National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl Trop Dis (2007) 1.95

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89

Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis (2009) 1.88

Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis (2009) 1.82

Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis (2006) 1.79

Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg (2008) 1.70

Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol (2010) 1.70

Enzootic Angiostrongylus cantonensis in rats and snails after an outbreak of human eosinophilic meningitis, Jamaica. Emerg Infect Dis (2002) 1.68

Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol (2003) 1.65

Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol (2008) 1.65

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl Trop Dis (2013) 1.64

Molecular mimicry between cockroach and helminth glutathione S-transferases promotes cross-reactivity and cross-sensitization. J Allergy Clin Immunol (2012) 1.58

A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLoS Negl Trop Dis (2010) 1.54

Genomics of Loa loa, a Wolbachia-free filarial parasite of humans. Nat Genet (2013) 1.52

Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J Immunol (2006) 1.52

Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl Trop Dis (2013) 1.52

Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis (2012) 1.50

Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol (2010) 1.50

The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg (2005) 1.49

Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg (2013) 1.48

Participation in three consecutive mass drug administrations in Leogane, Haiti. Trop Med Int Health (2006) 1.46

Nodding syndrome. Emerg Infect Dis (2013) 1.45

Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. Am J Trop Med Hyg (2011) 1.45

Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg (2004) 1.44

Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun (2004) 1.43

Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis (2009) 1.43

At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J Immunol (2010) 1.42

Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the americas: breaking a historical legacy of slavery. PLoS Negl Trop Dis (2007) 1.41

CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis (2012) 1.40

Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg (2004) 1.40

PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment. Filaria J (2003) 1.39

A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Trop (2010) 1.38

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood (2003) 1.37

Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis (2002) 1.36

An Epidemiologic Investigation of Potential Risk Factors for Nodding Syndrome in Kitgum District, Uganda. PLoS One (2013) 1.36

The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epidemiol (2015) 1.36

Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis (2013) 1.36

KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol (2007) 1.33

A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl Trop Dis (2012) 1.32

Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti. Am J Trop Med Hyg (2008) 1.32

Endpoints for lymphatic filariasis programs. Emerg Infect Dis (2007) 1.32

Parasite antigen-driven basophils are a major source of IL-4 in human filarial infections. J Immunol (2004) 1.32

Subconjunctival filariasis due to Onchocerca sp. in dogs: report of 23 cases in Greece. Vet Ophthalmol (2002) 1.31

Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol (2005) 1.31

Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis (2009) 1.30

Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood (2008) 1.27

Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis (2011) 1.26

Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti. Trans R Soc Trop Med Hyg (2004) 1.26

Molecular and morphologic characterization of a Cryptosporidium genotype identified in lemurs. Vet Parasitol (2003) 1.26

Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl Trop Dis (2007) 1.26

Ownership and usage of insecticide-treated bed nets after free distribution via a voucher system in two provinces of Mozambique. Malar J (2010) 1.26

International Society for Analytical Cytology biosafety standard for sorting of unfixed cells. Cytometry A (2007) 1.24

Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun (2004) 1.24

Development of a new platform for neglected tropical disease surveillance. Int J Parasitol (2012) 1.23

Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. Am J Trop Med Hyg (2003) 1.23

Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis (2012) 1.23

Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood (2003) 1.21

Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling. Lymphat Res Biol (2009) 1.21

Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population. J Immunol (2009) 1.21

Class and subclass selection in parasite-specific antibody responses. Trends Parasitol (2003) 1.21

Comparative genomics of gene expression in the parasitic and free-living nematodes Strongyloides stercoralis and Caenorhabditis elegans. Genome Res (2004) 1.20

Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci U S A (2011) 1.20

Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol (2003) 1.19

Immunopathogenesis of lymphatic filarial disease. Semin Immunopathol (2012) 1.19

Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence. Filaria J (2004) 1.19

Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One (2012) 1.19

A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations. Am J Trop Med Hyg (2013) 1.19

Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg (2002) 1.19

High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya. Parasit Vectors (2012) 1.18